Tim-3 finds its place in the cancer immunotherapy landscape.

Acharya, Nandini; Sabatos-Peyton, Catherine; Anderson, Ana Carrizosa

Acharya, Nandini; Sabatos-Peyton, Catherine; Anderson, Ana Carrizosa.

Afiliación

Acharya N; Department of Neurology, Evergrande Center for Immunologic Diseases and Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Sabatos-Peyton C; Harvard Medical School, Boston, Massachusetts, USA.
Anderson AC; Exploratory Immuno-oncology, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.

J Immunother Cancer ; 8(1)2020 06.

Article en En | MEDLINE | ID: mdl-32601081

Asunto(s)

Receptor 2 Celular del Virus de la Hepatitis A/metabolismo; Inmunoterapia/métodos; Neoplasias/inmunología; Humanos; Microambiente Tumoral

Palabras clave

clinical trials as topic; costimulatory and inhibitory T-cell receptors; immunotherapy; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor 2 Celular del Virus de la Hepatitis A / Inmunoterapia / Neoplasias Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google